[gowld]

> If you think their profit is 'exorbitant', then you should be investing in pharma.

is not necessarily true. Expected future returns are already priced into stock of incumbents.

[darawk]

You're correct. But look at their PE multiples and their margins. They're not wildly out of line with other companies.